![Douglas Lind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Lind
Keine laufenden Positionen mehr
Profil
Douglas D.
Lind is currently Chief Executive Officer at Apik Bio LLC since 2026.
Dr. Lind is also Co-President & Director at TMune Therapeutics, Inc., Director at HyperMed Imaging, Inc., and Director at Lentigen Technology, Inc. Former roles include Director at Viragen, Inc., MabVax Therapeutics, Inc., Opus Bio, Inc., Strand Life Sciences Pvt Ltd., Spectral Image, Inc., Flexible Stenting Solutions, Inc., and Enveric Biosciences, Inc. Dr. Lind was Managing Director at Burrill LLC from 2012 to 2013, Managing Director at GBP Capital, Managing Director at Biomark Capital Management Co. LLC from 2006 to 2025, Analyst at Morgan Stanley & Co. LLC in 2002, and Research Analyst at PaineWebber, Inc. in 1996.
Education includes graduate studies at the University of Iowa.
Aktive Positionen von Douglas Lind
| Unternehmen | Position | Beginn |
|---|---|---|
TMune Therapeutics, Inc.
 TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Präsident | - |
HyperMed Imaging, Inc.
 HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device | Direktor/Vorstandsmitglied | - |
Lentigen Technology, Inc.
 Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Douglas Lind
| Unternehmen | Position | Ende |
|---|---|---|
Biomark Capital Management Co. LLC
 Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Private Equity Investor | 01.01.2025 |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Private Equity Investor | 31.10.2013 |
Viragen, Inc.
 Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products | Direktor/Vorstandsmitglied | 01.02.2005 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 24.01.2002 |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Corporate Officer/Principal | 31.12.1996 |
Ausbildung von Douglas Lind
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Viragen, Inc.
Viragen, Inc. BiotechnologyHealth Technology Develops and researches immunological products | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Developed and commercialized immunotherapeutics for the treatment of cancer | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Burrill LLC
Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
PaineWebber, Inc.
PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opus Bio, Inc.
 Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures lentiviral gene delivery technologies | Commercial Services |
Strand Life Sciences Pvt Ltd.
 Strand Life Sciences Pvt Ltd. Packaged SoftwareTechnology Services Develops bioinformatics and clinical diagnostic software | Technology Services |
GBP Capital
 GBP Capital Investment ManagersFinance GBP Capital provides venture funding and assistance to early and mid-stage life science companies. They target companies with unique approaches to diagnostics, therapeutics and medical devices. GBP Capital focuses on investing in companies with technologies that leverage and build upon medical breakthroughs, as well as other major developments taking place within the life-sciences industry. | Finance |
Spectral Image, Inc.
 Spectral Image, Inc. Medical SpecialtiesHealth Technology Develops imaging technology for biomedical use | Health Technology |
Flexible Stenting Solutions, Inc.
 Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents | Health Services |
TMune Therapeutics, Inc.
TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Health Technology |
HyperMed Imaging, Inc.
HyperMed Imaging, Inc. Medical SpecialtiesHealth Technology Manufactures medical imaging device | Health Technology |
Biomark Capital Management Co. LLC
Biomark Capital Management Co. LLC Investment ManagersFinance Biomark Capital invests in companies located in the United States primarily in North America, along with a specific focus in Russia, Taiwan, India and China. The firm targets companies operating in the fields of the therapeutics, medical devices, molecular diagnostics, healthcare delivery and information technology service sectors. It provides financing for early, mid and later stage capital transactions with an investment size of USD 5 - 10 million. | Finance |
Lentigen Technology, Inc.
Lentigen Technology, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Enveric Biosciences, Inc.
 Enveric Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Develops cannabinoid medicines and combination therapies | Health Technology |
